http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-43125-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-234
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
filingDate 1975-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-43125-L
titleOfInvention Aminoglycoside derivative
abstract There are disclosed pharmaceutically-active aminoglycosides comprising 4-O-[2',6'-diamino 2',3',6'-tridesoxy alpha ,D-ribohexopyranosyl] 6-O-[3''-methylamino 3'',4'',6''-tridesoxy alpha ,D-xylohexopyranosyl] 2-desoxystreptamine of the formula: <IMAGE> (I) and the addition salts thereof with mineral acids or organic acids. Also disclosed are methods for preparation of the novel products as well as certain novel intermediate products. There are also disclosed pharmaceutical compositions in which the novel products are the active agents and a method for the treatment of bacteria infections in humans and animals.n[US4031210A]
priorityDate 1974-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID203443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585658

Total number of triples: 18.